current glp-1 drugs Comparing Ozempic, Wegovy and Other GLP-1 Agonists Explained: Definition, How
Description
2020 Sep 1;319(3):F458-F468
Introduced around the 2000s, these drugs have opened new avenues in weight management strategies, heralding a paradigm shift in obesity treatment
141 Recent evidence from a large-scale prospective cohort study involving 8.3 million individuals suggests that ACE inhibitors, which are often used in combination with DPP4 inhibitors, are safe and may even reduce the incidence of severe COVID-19 and its complications
Its most critical role during GLP-1 therapy is helping to preserve lean muscle mass
2021;8(5):rbab042
& Moran, L
